Regeneron share price logo

Regeneron

NASDAQ: REGN

Large Cap

$828.50

-5.54

(-0.66%)

as on

Regeneron Stock Performance

as on August 25, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $823.39
    $834.70
    downward going graph

    0.62%

    Downside

    0.75%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $541.00
    $821.11
    downward going graph

    34.70%

    Downside

    -0.89%

    Upside

    downward going graph

Regeneron share price movements today

Previous Close
$834.04
Open
$834.70
Volume
300.5K
Market Cap
$82.7B
Dividend Yield
0.45%
Day's Low - High
$823.39 - $834.70
52 Week Low - High
$541.00 - $821.11

Regeneron Historical Returns

1 Month Return
+ 18.74 %
3 Month Return
+ 15.07 %
1 Year Return
+ 38.43 %
3 Year Return
+ 0.85 %
5 Year Return
+ 24.1 %

Regeneron Stock Fundamentals & Key Indicators

Check Regeneron market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$82.7B

EPS (TTM)

41.88

Dividend Yield

0.45%

Quarterly Earnings Growth YOY

-0.04%

PE Ratio (TTM)

19.24

Industry PE ratio

10.197

PEG Ratio

61.805244838733515

EBITDA

5.8B

Revenue (TTM)

15.5B

Profit Margin

84.86%

Return On Equity TTM

13.81%

Regeneron Stock Valuation

Track how Regeneron P/E has moved over time to understand its valuation trends.

Regeneron in the last 5 years

  • Overview

  • Trends

Lowest (8.27x)

December 31, 2021

Industry (10.20x)

December 31, 2025

Today (17.92x)

December 31, 2025

Highest (23.70x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: 17.92x

Regeneron vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Regeneron with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$82.7B24.1%19.2484.86%0.44999999999999996%
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA

Stock Returns calculator for Regeneron Stock including INR - Dollar returns

The Regeneron stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Regeneron investment value today

Current value as on today

₹1,55,985

Returns

₹55,985

(+55.98%)

Returns from Regeneron Stock

₹42,744 (+42.74%)

Dollar Impact

₹13,241 (+13.24%)

Analyst Recommendation on Regeneron Stock

Based on 21 analysts

BUY

66.67%

Buy

33.33%

Hold

0.00%

Sell

Based on 21 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Regeneron. Average target price of $833.65

Regeneron Share Price Target

Get share price movements and forecasts by analysts on Regeneron.

What analysts predicted

0.62%UPSIDE

Target Price

$833.65

Current Price

$828.5

Analyzed by

21 Analysts

Target

$833.65

Regeneron target price $833.65, a slight upside of 0.62% compared to current price of $828.5. According to 21 analysts rating.

Indian Investors' Interest in Regeneron Stock

Investment in Regeneron Shares on INDmoney has grown by 28.57% in the last 30 days, indicating increased investment activity.

Time period: to

Change:28.57% versus previous 30 day period

Search interest for Regeneron Stock has increased by 13% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:13% versus previous 30 day period

Regeneron Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
3,145
3,547
3,720
3,789
3,028
3,675
3,754
3,884
3,605
4,290
Gross Profit
2,711
3,066
3,229
3,223
2,564
3,145
3,232
3,299
2,936
3,714
Operating Income
751
1,069
1,179
990
591
1,079
1,026
879
642
1,420
EBITDA
830
1,763
1,628
1,095
1,040
1,657
1,919
1,200
967
1,662
Interest Expense
16
14
13
10
8
3
19
12
12
11
Depreciation
114
120
121
126
126
135
136
145
123
123
Income Before Tax
700
1,628
1,493
958
905
1,518
1,763
1,043
831
1,527
Income Tax Expense
-21
195
152
40
96
127
303
199
104
230
Net Income
722
1,432
1,340
917
808
1,391
1,460
844
727
1,296
Net Profit Margin
86.21%
86.46%
86.80%
85.08%
84.67%
85.58%
86.11%
84.95%
81.43%
86.56%

Regeneron Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
5,872
6,710
6,557
8,497
16,071
12,172
13,117
14,202
14,342
Gross Profit
5,329
6,128
5,582
7,141
13,348
10,467
10,872
12,231
12,242
Operating Income
2,079
2,534
2,209
3,576
8,946
5,385
4,348
3,990
3,577
EBITDA
2,249
2,729
2,669
4,103
9,669
5,259
4,693
5,318
5,818
Interest Expense
25
28
30
56
57
59
73
55
43
Depreciation
145
148
210
235
286
341
421
482
543
Income Before Tax
2,078
2,553
2,429
3,810
9,325
4,858
4,199
4,779
5,230
Income Tax Expense
880
109
313
297
1,250
520
245
367
725
Net Income
1,198
2,444
2,115
3,513
8,075
4,338
3,953
4,412
4,504
Net Profit Margin
90.76%
91.32%
85.13%
84.04%
83.05%
85.99%
82.89%
86.13%
85.35%

Regeneron Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
722
1,432
1,340
917
808
1,391
1,460
844
727
1,296
Operating Cash Flow
1,512
354
1,291
1,262
1,045
1,144
1,618
1,170
1,078
574
Investing Cash Flow
-1,687
-557
-574
350
647
-1,094
-402
220
-428
-92
Financing Cash Flow
47
-478
-634
-1,135
-1,089
-1,128
-717
-780
-802
-2,344
Change in Cash
-128
-681
83
477
604
-1,077
497
610
-153
-1,863

Regeneron Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
1,198
2,444
2,115
3,513
8,075
4,338
3,953
4,412
4,504
Operating Cash Flow
1,307
2,195
2,430
2,618
7,081
5,014
4,594
4,420
4,978
Investing Cash Flow
-1,005
-1,463
-2,027
-70
-5,384
-3,784
-3,185
-2,468
-629
Financing Cash Flow
-24
-77
-252
-1,970
-1,005
-1,009
-1,790
-2,200
-3,715
Change in Cash
277
655
150
577
690
221
-381
-248
634

Mutual Funds that own Regeneron Stock

Check out the Mutual Funds with significant holdings in Regeneron.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
6.86711%
6945247
Dodge & Cox Funds
3.373273%
3411656
Fidelity Concord Street Trust
1.755391%
1775365
Putnam Large Cap Value Fund
1.12977%
1142625
VANGUARD SPECIALIZED FUNDS
0.921401%
931886

Global Institutional Holdings in Regeneron

Funds
Holdings
Vanguard
9.35%
iShares
5.59%
John A. Gunn
4.82%
Invesco
4.35%
SPDR
4.09%

Regeneron News & Key Events

  • img

    Today's Timeline - 20 August

    Thu, 08:06 PM

    -

    Regeneron receives FDA approval for Pasatru to treat fibrodysplasia ossificans progressiva, based on positive OPTIMA study results.

Insights on Regeneron

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Regeneron Pharmaceuticals, Inc. has shown strong financial performance, with its net profit increasing for the last two quarters. It rose from $727.20 million to $1.29 billion, demonstrating an average increase of 43.9% each quarter.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Regeneron Pharmaceuticals has shown strong revenue growth over the last two quarters. The revenue increased from $3.60 billion to $4.29 billion, reflecting an average increase of 16.0% per quarter.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, REGN stock has moved up by 26.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 493.2% return, outperforming this stock by 448.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 538.4% return, outperforming this stock by 538.6%

About Regeneron

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; neovascular glaucoma; retinopathy of prematurity; Dupixent injection to treat atopic dermatitis and asthma; Libtayo injection for metastatic or locally advanced cutaneous squamous cell carcinoma; Praluent injection to treat heterozygous familial hypercholesterolemia (HoFH); and Kevzara solution for rheumatoid arthritis. It has license and collaboration agreement with Bayer for the development and commercialization of EYLEA 8 mg and EYLEA; Alnylam Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for diseases by addressing therapeutic disease targets expressed in the eye and central nervous system; Intellia Therapeutics, Inc. to advance CRISPR/Cas9 gene-editing technology for in vivo therapeutic development for therapies focused on neurological and muscular diseases; Hansoh Pharmaceuticals Group Company Limited to acquire development and commercial rights for HS-20094, a dual GLP-1/GIP receptor; and Tessera Therapeutics, Inc. develops and commercializes TSRA-196, an investigational gene editing therapy for Alpha-1 antitrypsin deficiency. Additionally, the company has a strategic collaboration with Telix Pharmaceuticals Limited to develop and commercialize radiopharmaceutical therapies. It also has a strategic collaboration with CytomX Therapeutics, Inc. to create conditionally-activated bispecific cancer therapies. The company was incorporated in 1988 and is based in Tarrytown, New York.
OrganisationRegeneron
Headquarters777 Old Saw Mill River Road, Tarrytown, NY, United States, 10591-6707
IndustryBiotechnology
CEODr. Leonard S. Schleifer M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Regeneron

Name

Title

Mr. Rajesh Ahuja

Senior Vice President of Quality Assurance & Operations

Mr. Ryan Crowe

Senior Vice President of Investor Relations & Strategic Analysis

Dr. Leonard S. Schleifer M.D., Ph.D.

Co-Founder, President, CEO & Co-Chairman

Dr. George D. Yancopoulos M.D., Ph.D.

Co-Founder, President, Chief Scientific Officer & Co-Chairman

Dr. Andrew J. Murphy Ph.D.

Executive VP of Research & Co-Chief Scientific Officer

Mr. Daniel P. Van Plew

Executive VP and GM of Industrial Operations & Product Supply

Mr. Christopher R. Fenimore CPA

Executive VP of Finance & CFO

Mr. Joseph J. LaRosa J.D.

Executive VP, General Counsel & Secretary

Mr. Ryan Steinberger

Executive VP, Chief Digital & Technology Officer

Ms. Melissa Lozner

Senior VP & Chief Compliance Officer

FAQs

What is Regeneron share price today?

Regeneron share price today is $828.50 as on at the close of the market. Regeneron share today touched a day high of $834.70 and a low of $823.39.

What is the 52 week high and 52 week low for Regeneron share?

Regeneron share touched a 52 week high of $821.11 on and a 52 week low of $541.00 on . Regeneron stock price today i.e. is closed at $828.50,which is -0.90% down from its 52 week high and 53.14% up from its 52 week low.

What is Regeneron's market capitalisation today?

Regeneron market capitalisation is $0.08T as on .

How to invest in Regeneron Stock (REGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Regeneron on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Regeneron Shares that will get you 0.0018 shares as per Regeneron share price of $828.50 per share as on August 25, 2026 at 8:46 am IST.

What is the minimum amount required to buy Regeneron Stock (REGN) from India?

Indian investors can start investing in Regeneron (REGN) shares with as little as ₹95.735 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.35 in Regeneron stock (as per the Rupee-Dollar exchange rate as on ). Based on Regeneron share’s latest price of $828.50 as on August 25, 2026 at 8:46 am IST, you will get 0.0121 shares of Regeneron. Learn more about fractional shares .

What are the returns that Regeneron has given to Indian investors in the last 5 years?

Regeneron stock has given 24.1% share price returns and 29.09% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?